Global Presence
Research, management, quality control and marketing synergy drive our development worldwide including product export, technology transfer and supply chain development.
OUR EXPORT DESTINATIONS
Armenia
Azerbaijan
Bangladesh
Belarus
Bolivia
Cambodia
Cote D’Ivoire
Dominican Republic
Georgia
Guatemala
Honduras
India
Iraq
Kazakhstan
Kenya
Kyrgyzstan
Mexico
Moldova
Mongolia
Morocco
Nicaragua
Panama
Pakistan
Philippines
Senegal
Sri Lanka
UAE
Uganda
Uzbekistan
Vietnam
Yemen
LATEST INTERNATIONAL POSTS
canSERV rolls out cancer research services across Europe
The European canSERV project – which aspires to defragment the landscape of European cancer research – commences in Brussels today. Over the next three years,
Positive in vitro results for Imutex’s FLU-v
Data further supports the continued development of FLU-v as a broad-spectrum influenza vaccine Open Orphan – a company that tests infectious and respiratory disease products
Exelixis announces results from trial evaluating XB002
Study involves patients with advanced common cancers and solid tumours Exelixis has announced promising initial results from the ongoing dose-escalation stage of JEWEL-101 – a
QiC Diabetes awards 2022 celebrate UK healthcare excellence
This year, the annual Quality in Care (QiC) Diabetes awards were held at Sanofi’s head office in Reading on 13 October. Back for the twelfth
Apogenix’s asunercept demonstrates efficacy in COVID-19 trial
Therapy showed faster clinical recovery for combined treatment groups Apogenix’s asunercept treatment has shown statistically significant benefits for hospitalised COVID-19 patients in its Asunctis trial.
Stop TB Partnership sounds the alarm on tuberculosis funding crisis
TB deaths increase for second year in a row and cases rise for the first time in 20 years. New data released by the World
